Press Releases Aeterna Zentaris Inc.

Equities

AEZS

CA0079756007

Market Closed - Toronto S.E. Other stock markets 03:57:59 2024-06-04 pm EDT			5-day change	1st Jan Change
10.94 ^CAD	-4.87%		-5.03%	+6.42%

Jun. 03	Aeterna and Ceapro Brief: Cos Complete Merger Transaction; New Name Expected to be Announced in Coming Weeks and Details of AGM Expected to be Announced Shortly	MT
Jun. 03	Aeterna Zentaris Inc. completed the acquisition of Ceapro Inc. in a merger of equals transaction.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aeterna Zentaris and Ceapro Complete Merger Transaction	Jun. 03	AQ
Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date	May. 29	AQ
Aeterna Zentaris Announces Details Regarding Transaction with Ceapro	May. 17	AQ
Aeterna Zentaris : Condensed Interim Consolidated Financial Statements As of March 31, 2024, and for the three months ended March 31, 2024, and 2023 - Form 6-K	May. 16	PU
Aeterna Zentaris : Audited Consolidated Financial Statements of Ceapro Inc. as of December 31, 2023 and 2022 and for the years ended December 31, 2023 and 2022 - Form 6-K	May. 15	PU
Aeterna Zentaris Reports First Quarter 2024 Financial Results	May. 14	AQ
Aeterna Zentaris : MATERIAL CHANGE REPORT - Form 6-K	May. 09	PU
Aeterna Zentaris Announces Effective Date of Share Consolidation	May. 01	AQ
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency	Mar. 27	AQ
Aeterna Zentaris : Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency - Form 6-K	Mar. 27	PU
Aeterna Zentaris : Consolidated Financial Statements As of December 31, 2023 and 2022 and for the years ended December 31, 2023, 2022 and 2021 - Form 6-K	Mar. 27	PU
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings	Mar. 12	AQ
Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro	Feb. 15	AQ
AEZS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aeterna Zentaris Inc. Is Fair to Shareholders	Dec. 14	BU
Canadian Investment Regulatory Organization Trade Resumption - AEZS	Dec. 14	AQ
Canadian Investment Regulatory Organization Trading Halt - AEZS	Dec. 14	AQ
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company	Dec. 14	AQ
Aeterna Zentaris Reports Third Quarter 2023 Financial Results	Nov. 09	AQ
Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO Conference	23-10-11	AQ
Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment Conference	23-09-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Aeterna Zentaris Inc.

Equities

AEZS

CA0079756007

Press Releases

Filters